The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation
Abstract
Parkinson's disease (PD) is a movement disorder characterized by a progressive loss of nigrostriatal dopaminergic neurons. Microglia activation and neuroinflammation have been associated with the pathogenesis of PD. Indeed, cytokines have been proposed as candidates that mediate the apoptotic cell death of dopaminergic neurons seen in PD. In this study, we investigated the effect of two natural polyphenols, resveratrol and quercetin, on neuroinflammation. For glial cells, we observed that lipopolysaccharide (LPS)‐induced mRNA levels of two proinflammatory genes, interleukin 1‐α and tumor necrosis factor‐α, are strongly decreased by treatments with resveratrol or quercetin. We also undertook microglial‐neuronal coculture to examine the influence of resveratrol and quercetin on dopaminergic neuronal cell death evoked by LPS‐activated microglia. Cytotoxicity assays were performed to evaluate the percentage of cell death, with apoptotic cells identified by both the TdT‐mediated dUTP nick end labeling technique and the detection of cleaved caspase‐3. We report that treatment of N9 microglial cells with resveratrol or quercetin successfully reduced the inflammation‐mediated apoptotic death of neuronal cells in our coculture system. Altogether our results demonstrate that resveratrol and quercetin diminished apoptotic neuronal cell death induced by microglial activation and suggest that these two phytoestrogens may be potent antiinflammatory compounds. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
D IETARY F LAVONOIDS: Bioavailability, Metabolic Effects, and Safety
Ross, J. A., & Kasum, C. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.111401.144957 · Cited by 2,151
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 2×
“In addition, the SN is the brain region with the highest density of microglial cells (Lawson et al., 1990); thus, the neurons of this region are particularly susceptible to microglial-mediated toxicity in vitro and in vivo (Kim et al.”
BackgroundReview of the biology of quercetin and related bioflavonoids
Formica, J. V., & Regelson, W. (1995) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00077-1 · Cited by 1,765
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
Decker, T., & Lohmann-Matthes, M.-L. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90310-9 · Cited by 1,359
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 1×
“Activation of microglia leads to an increase in the production of cytokines that could mediate neuronal apoptosis and precedes degeneration of DA nigrostriatal neurons in a PD mouse model (Liberatore et al., 1999).”
BackgroundKim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Neuroprotection against Oxidative Stress by Estrogens: Structure-Activity Relationship
Behl, C., Skutella, T., Lezoualc’H, F., Post, A., Widmann, M., Newton, C. J., & Holsboer, F. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.535 · Cited by 762
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Microglia in health and disease
Kim, S. U., & de Vellis, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20562 · Cited by 663
Kim, Y. S., & Joh, T. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.40 · Cited by 655
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Bowers, J. L., Tyulmenkov, V. V., Jernigan, S. C., & Klinge, C. M. (2000) · Endocrinology · doi:10.1210/endo.141.10.7721 · Cited by 526
Resveratrol: from grapevines to mammalian biology
Pervaiz, S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0168rev · Cited by 520
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 472
Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia
Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F., Brusadelli, A., Viviani, B., Ciana, P., & Maggi, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01809.2001 · Cited by 471
Moosmann, B., & Behl, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.8867 · Cited by 411
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., & Isacson, O. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406
Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol
Vegeto, E., Belcredito, S., Etteri, S., Ghisletti, S., Brusadelli, A., Meda, C., Krust, A., Dupont, S., Ciana, P., Chambon, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531957100 · Cited by 382
Antiinflammatory Effects of Estrogen on Microglial Activation1
Bruce-Keller, A. J., Keeling, J. L., Keller, J. N., Huang, F. F., Camondola, S., & Mattson, M. P. (2000) · Endocrinology · doi:10.1210/endo.141.10.7693 · Cited by 362
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Hunter, R. L., Dragicevic, N., Seifert, K., Choi, D. Y., Liu, M., Kim, H., Cass, W. A., Sullivan, P. G., & Bing, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04327.x · Cited by 322
Casagrande, F., & Darbon, J.-M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00583-4 · Cited by 303
Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia
Bi, X. L., Yang, J. Y., Dong, Y. X., Wang, J. M., Cui, Y. H., Ikeshima, T., Zhao, Y. Q., & Wu, C. F. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.008 · Cited by 274
Resveratrol in Cardioprotection: A Therapeutic Promise of Alternative Medicine
Das, D. K. (2006) · Molecular Interventions · doi:10.1124/mi.6.1.7 · Cited by 258
Estradiol upregulates Bcl-2 expression in adult brain neurons
Garcia-Segura, L. M., Cardona-Gomez, P., Naftolin, F., & Chowen, J. A. (1998) · NeuroReport · doi:10.1097/00001756-199803090-00006 · Cited by 253
Protective Effects of Quercetin and Vitamin C against Oxidative Stress-Induced Neurodegeneration
Heo, H. J., & Lee, C. Y. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf049243r · Cited by 249
Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · cited 1×
“The cytokines TNFa, IL-1a, IL-1b, and IL-6 have also been identified in PD animal models (Czlonkowska et al., 1996; Kohutnicka et al., 1998; Sriram et al., 2006).”
BackgroundMercer, L. D., Kelly, B. L., Horne, M. K., & Beart, P. M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.018 · Cited by 241
Postmenopausal Estrogen Use Affects Risk for Parkinson Disease
Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P., & Wooten, G. F. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.886 · Cited by 226
Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice
Aubin, N., Curet, O., Deffois, A., & Carter, C. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041635.x · Cited by 214
Jang, J.-H., & Surh, Y.-J. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00233-9 · Cited by 209
Morale, M. C., Serra, P. A., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M. S., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.060 · Cited by 207
Liu, Y., Qin, L., Li, G., Zhang, W., An, L., Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043166 · Cited by 205
Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
Basly, J.-P., Marre-Fournier, F., Le Bail, J.-C., Habrioux, G., & Chulia, A. J. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00650-5 · Cited by 179
Marchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175 · cited 1×
“Journal of Neuroscience Research DOI 10.1002/jnr McGeer et al., 2005; Morale et al., 2006), and, in particular, the development of PD pathogenesis has been closely associated with the presence of several markers of inflammation in the SN (Marchetti and Abbracchio, 2005; Hunter et al., 2007).”
BackgroundInfluentialBreast cancer risk with postmenopausal hormonal treatment
Collins, J. A., Blake, J. M., & Crosignani, P. G. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi028 · Cited by 172
Shigematsu, S., Ishida, S., Hara, M., Takahashi, N., Yoshimatsu, H., Sakata, T., & Korthuis, R. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01430-2 · Cited by 171
Inflammation, the complement system and the diseases of aging
McGeer, E. G., Klegeris, A., & McGeer, P. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.008 · Cited by 170
Arimoto, T., Choi, D., Lü, X., Liu, M., Nguyen, X. V., Zheng, N., Stewart, C. A., Kim, H., & Bing, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.011 · Cited by 163
Gélinas, S., & Martinoli, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10315 · Cited by 155
Self-citationLi, F.-Q., Wang, T., Pei, Z., Liu, B., & Hong, J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0213-0 · Cited by 147
Estrogen Hormones Reduce Lipid Peroxidation in Cells and Tissues of the Central Nervous System
Vedder, H., Anthes, N., Stumm, G., Würz, C., Behl, C., & Krieg, J. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722531.x · Cited by 145
Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis
Ulrich, S., Wolter, F., & Stein, J. M. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400081 · Cited by 138
Vitamin E suppression of microglial activation is neuroprotective
Li, Y., Liu, L., Barger, S. W., Mrak, R. E., & Griffin, W. S. T. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1208 · Cited by 131
Arai, H., Furuya, T., Yasuda, T., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407328200 · Cited by 122
Herrera, A. J., Tomás‐Camardiel, M., Venero, J. L., Cano, J., & Machado, A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0121-3 · Cited by 116
Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model
Sawada, H., Ibi, M., Kihara, T., Honda, K., Nakamizo, T., Kanki, R., Nakanishi, M., Sakka, N., Akaike, A., & Shimohama, S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00049-7 · Cited by 114
Neuroprotective activities of estrogen: An update
Behl, C., & Manthey, D. (2000) · Journal of Neurocytology · doi:10.1023/a:1007109222673 · Cited by 111
Sairam, K., Saravanan, K. S., Banerjee, R., & Mohanakumar, K. P. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04174-4 · Cited by 106
Jin, D., Lim, C. S., Hwang, J. K., Ha, I., & Han, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.036 · Cited by 106
Brookes, P. S., Digerness, S. B., Parks, D. A., & Darley-Usmar, V. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00839-0 · Cited by 105
Acid phosphatase: Endpoint for in vitro toxicity tests
Martin, A. J., & CLYNES, M. M. (1991) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02630912 · Cited by 103
Sribnick, E. A., Ray, S. K., Nowak, M. W., Li, L., & Banik, N. L. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20124 · Cited by 89
Walther, M. R., Kuklinski, S., Pesheva, P., Guntinas‐Lichius, O., Angelov, D. N., Neiss, W. F., Asou, H., & Probstmeier, R. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000815)61:4<430::aid-jnr9>3.0.co;2-3 · Cited by 87
Wang, X., Chen, S., Ma, G., Ye, M., & Lü, G. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.06.012 · Cited by 83
Rao, Y. K., Fang, S., & Tzeng, Y. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.912 · Cited by 80
Gollapudi, L. A., & Oblinger, M. M. (1999) · Journal of Neuroscience Research · Cited by 80
Ferger, B., Teismann, P., Earl, C. D., Kuschinsky, K., & Oertel, W. H. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900079 · Cited by 71
Carrasco, E., Casper, D., & Werner, P. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20541 · Cited by 66
Yen, G., & Lai, H.-H. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034876b · Cited by 62
Liao, S., Chen, W., & Chen, C. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00754-1 · Cited by 47
Gélinas, S., Bureau, G. P., Valastro, B., et al. (2004) · Neurotoxicity Research · doi:10.1007/bf03033216 · Cited by 36
Self-citationGagne, B., Gélinas, S., Bureau, G., Lagacé, B., Ramassamy, C., Chiasson, K., Valastro, B., & Martinoli, M. (2003) · Endocrine · doi:10.1385/endo:21:1:89 · Cited by 30
Self-citationConsequences of long-term hormone replacement therapy
Purdie, D. W. (2000) · British Medical Bulletin · doi:10.1258/0007142001903382 · Cited by 21
Cited by
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Quercetin, Inflammation and Immunity
Li, Y., Yao, J., Han, C., Yang, J., Chaudhry, M., Wang, S., Liu, H., & Yin, Y. (2016) · Nutrients · doi:10.3390/nu8030167 · Cited by 1,999
“Moreover, in glial cells it was even shown that quercetin can inhibit LPS-induced mRNA levels of TNF-α and interleukin (IL)-1α, this effect of quercetin resulted in a diminished apoptotic neuronal cell death induced by microglial activation [47].”
BackgroundInfluentialWang, W., Sun, C., Mao, L., Ma, P., Liu, F., Yang, J., & Gao, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.07.004 · Cited by 784
Batiha, G. E.-S., Beshbishy, A. M., Ikram, M., Mulla, Z. S., El-Hack, M. E. A., Taha, A. E., Algammal, A. M., & Elewa, Y. H. A. (2020) · Foods · doi:10.3390/foods9030374 · Cited by 709
Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine
Yang, D., Wang, T., Long, M., & Li, P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8825387 · Cited by 638
Metadata
- Authors
- Bureau, G., Longpré, F., & Martinoli, M. ‐.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2007-10-10
- Volume
- 86
- Issue
- 2
- Pages
- 403-410
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2039348922
- Cited by
- 334
- References
- 71
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.